CD4 and primary cutaneous T-cell non-Hodgkin lymphoma: Sézary syndrome (SS) is a rare leukemic variant of cutaneous T-cell lymphoma (CTCL) characterized by a malignant monoclonal proliferation of mature CD4+ T-cells named Sézary cells (1) for which current available treatments do not provide long-term responses (2).